Benzamide, N,2-dihydroxy-4-methyl-(158671-29-5)
- Name: Benzamide, N,2-dihydroxy-4-methyl-
- Synonyms:4-Methylsalicylhydroxamic acid;N,2-Dihydroxy-4-methylbenzamide;N-Hydroxy-2-hydroxy-4-methylbenzamide;
- Molecular Formula:C8H9NO3
- Molecular Weight:167.164
- CAS Registry Number:158671-29-5
- EINECS:808-484-2
- Melting Point:
- Water Solubility:
CAS No.158671-29-5 N,2-dihydroxy-4-methylbenzamide
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.158671-29-5 Benzamide, N,2-dihydroxy-4-methyl-
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Benzamide, N,2-dihydroxy-4-methyl-
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.158671-29-5 N,2-dihydroxy-4-methylbenzamide
Assay:99% Appearance:white powder Package:25kg,50kg,180kg,200kg,250kg,1000kg锛宑ustomization Storage:Keep it in dry,shady and cool place Transportation:by express or by sea Application:Pharma;Industry;Agricultural;chemical reaserch
Min. Order:0
Supplier:Wuhan Circle Star Chem-medical Technology co.,Ltd. [
China (Mainland)] CAS No.158671-29-5 N,2-Dihydroxy-4-methylbenzamide;158671-29-5
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 149456-98-4/Methanesulfonamide, N-[4-[2-(formylamino)acetyl]-5-methoxy-2-phenoxyphenyl]-
- 149457-03-4/Methanesulfonamide, N-[4-[2-(formylamino)acetyl]-5-hydroxy-2-phenoxyphenyl]-
- 1198178-65-2/Cyclopropanecarboxamide, 1-amino-N-(cyclopropylsulfonyl)-2-ethyl-, (1R,2R)-, 4-methylbenzenesulfonate (1:1)
- 120788-03-6/Ethanethioic acid, S-(tetrahydro-1-oxido-3-thienyl) ester, (1R-cis)- (9CI)
- 123664-84-6/Methanesulfonamide, N-(5-methoxy-2-phenoxyphenyl)-
- 1001859-46-6/RiferMinogene PecaplasMid
- 665058-78-6/DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-T-sp-C-G-sp-T-sp-T) (9CI)
- 67978-05-6/4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-(1-methylethenyl)-3-(4-methylphenyl)-7-oxo-, diphenylmethyl ester, [1R-[1α,5α,6(R*)]]- (9CI)
- 923591-06-4/3H,5H-2,23:5,8-Dimethano-1H-4,13,2,8,11-benzodioxatriazacycloheneicosine-7-carboxylic acid, 10-(1,1-dimethylethyl)-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-15,15-dimethyl-3,9,12-trioxo-, methyl ester, (5R,7S,10S)-
- 947408-94-8/1,2-Benzisoxazol-3(2H)-one, 6-methyl-2-(triphenylmethyl)-
- 947408-95-9/1,2-Benzisoxazol-3(2H)-one, 6-(bromomethyl)-2-(triphenylmethyl)-
- 947409-01-0/Benzenepropanoic acid, 5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[[2,3-dihydro-3-oxo-2-(triphenylmethyl)-1,2-benzisoxazol-6-yl]methoxy]-, methyl ester
- 913695-00-8/1H-Benzimidazole, 2-[[[4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (1:1), (+)-
- 472960-22-8/Serum albumin (human) fusion protein with interferon α2 (human)
- 762263-14-9/1-165-Erythropoietin (human), glycoform θ
- 869858-13-9/Thrombin (synthetic human) (9CI)
- 879555-13-2/1-165-Erythropoietin (human JR-013), glycoform κ (9CI)
- 897936-89-9/Blood-coagulation factor VII [158-aspartic acid,296-valine,298-glutamine] (synthetic human)
- 909110-25-4/β-Lymphotoxin receptor (human extracellular domain-containing fragment) fusion protein with immunoglobulin G1 (human γ1-chain Fc fragment)
- 158671-29-5/Benzamide, N,2-dihydroxy-4-methyl-
- 268544-50-9/2-[(2-Methoxy-2-oxoethoxy)imino]-3-oxobutanoic acid 1,1-dimethylethyl ester
- 855425-38-6/Cyclohexanecarbonitrile, 1-(2-ethylbutyl)-
- 910656-45-0/Butanoic acid, 2-hydroxy-2-(trifluoromethyl)-, hydrazide
- 579494-66-9/Benzeneacetic acid, 4-[2-(diethylamino)-2-oxoethoxy]-3-ethoxy-, propyl ester
- 610300-00-0/Octanoic acid, 3-amino-5-methyl-, hydrochloride (1:1), (3S,5R)-
- 702686-97-3/Benzenepropanoic acid, 3-[(2R)-3-[[2-(2,3-dihydro-1H-inden-2-yl)-1,1-dimethylethyl]amino]-2-hydroxypropoxy]-4,5-difluoro-, ethyl ester, hydrochloride (1:1)
- 945717-05-5/Benzeneethanamine, 4-chloro-3-ethyl-, hydrochloride (1:1)
- 945717-43-1/Benzeneethanamine, 4-chloro-N-[[4-(1,1-dimethylethyl)phenyl]methyl]-3-ethyl-
- 503070-58-4/Benzeneacetic acid, α,α-diphenyl-, compd. with (α1R)-α1-[[[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexyl]amino]methyl]-4-hydroxy-1,3-benzenedimethanol (1:1)
- 1035455-87-8/2-Propenoic acid, 3-[3-[(2R)-3-[[2-(2,3-dihydro-1H-inden-2-yl)-1,1-dimethylethyl]amino]-2-hydroxypropoxy]-4,5-difluorophenyl]-, ethyl ester, hydrochloride (1:1), (2E)-